BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34729183)

  • 1.
    Zhang Q; Cheng L; Qin Y; Kong L; Shi X; Hu J; Li L; Ding Z; Wang T; Shen J; Yang Y; Yu L; Liu B; Liu C; Qian X
    Clin Transl Immunology; 2021; 10(10):e1347. PubMed ID: 34729183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer.
    Li G; Li Q; Ping M; Jiao Z; Wang X; Cheng J; Guo J; Cheng Y
    Aging (Albany NY); 2024 May; 16(10):8944-8964. PubMed ID: 38787377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer.
    Zhang Y; Zhang Q; Han X; Han L; Wang T; Hu J; Li L; Ding Z; Shi X; Qian X
    Transl Oncol; 2023 May; 31():101654. PubMed ID: 36931016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma.
    Zou CY; Guan GF; Zhu C; Liu TQ; Guo Q; Cheng W; Wu AH
    CNS Neurosci Ther; 2019 Mar; 25(3):333-342. PubMed ID: 30105842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOX promotes the exhaustion of antitumor CD8
    Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
    J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PD1/PDL1 Expression and Their Clinicopathologic Association in EBV-associated Lymphoproliferative Disorders in Nonimmunosuppressed Patients.
    Guo L; Bodo J; Durkin L; Hsi ED
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):101-106. PubMed ID: 29084057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.
    Veloza L; Teixido C; Castrejon N; Climent F; Carrió A; Marginet M; Soldini D; González-Farré B; Ribera-Cortada I; Lopez-Guillermo A; González-Barca E; Sierra A; Herrera M; Gómez C; Garcia A; Balagué O; Campo E; Martinez A
    Histopathology; 2019 Dec; 75(6):799-812. PubMed ID: 30861172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation.
    Jing JJ; Wang ZY; Li H; Sun LP; Yuan Y
    Cancer Cell Int; 2018; 18():146. PubMed ID: 30258285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
    Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
    Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment.
    Wang YL; Gong Y; Lv Z; Li L; Yuan Y
    J Cancer; 2021; 12(6):1698-1707. PubMed ID: 33613757
    [No Abstract]   [Full Text] [Related]  

  • 11. Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma.
    Saung MT; Zheng L
    Ann Pancreat Cancer; 2019 Dec; 2():. PubMed ID: 32405624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer.
    Jiang Q; Tian C; Wu H; Min L; Chen H; Chen L; Liu F; Sun Y
    Chin J Cancer Res; 2022 Aug; 34(4):365-382. PubMed ID: 36199531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma.
    Shigeta K; Matsui A; Kikuchi H; Klein S; Mamessier E; Chen IX; Aoki S; Kitahara S; Inoue K; Shigeta A; Hato T; Ramjiawan RR; Staiculescu D; Zopf D; Fiebig L; Hobbs GS; Quaas A; Dima S; Popescu I; Huang P; Munn LL; Cobbold M; Goyal L; Zhu AX; Jain RK; Duda DG
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33234602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
    Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.
    Xing X; Guo J; Ding G; Li B; Dong B; Feng Q; Li S; Zhang J; Ying X; Cheng X; Guo T; Du H; Hu Y; Zhou T; Wang X; Li L; Li Q; Xie M; Li L; Gao X; Shan F; Li Z; Jia S; Wen X; Wang J; Ji J
    Oncoimmunology; 2018; 7(3):e1356144. PubMed ID: 29399387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
    Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
    Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancer.
    Oshima K; Shoji H; Boku N; Hirano H; Okita N; Takashima A; Kato K; Kudo-Saito C
    Am J Cancer Res; 2024; 14(3):1174-1189. PubMed ID: 38590413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
    Lepletier A; Madore J; O'Donnell JS; Johnston RL; Li XY; McDonald E; Ahern E; Kuchel A; Eastgate M; Pearson SA; Mallardo D; Ascierto PA; Massi D; Merelli B; Mandala M; Wilmott JS; Menzies AM; Leduc C; Stagg J; Routy B; Long GV; Scolyer RA; Bald T; Waddell N; Dougall WC; Teng MWL; Smyth MJ
    Clin Cancer Res; 2020 Jul; 26(14):3671-3681. PubMed ID: 32345648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined deficiency of SLAMF8 and SLAMF9 prevents endotoxin-induced liver inflammation by downregulating TLR4 expression on macrophages.
    Zeng X; Liu G; Peng W; He J; Cai C; Xiong W; Chen S; Yang M; Dong Z
    Cell Mol Immunol; 2020 Feb; 17(2):153-162. PubMed ID: 30552382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.